WINKAST-DL
MRP: 2,500
Packaging: 10X10
Pack Type: tablet
Composition:
Doxofyline 400mg + Levocetrizine 5mg + Montelukast 10mg
Indication:
Seasonal allergic Rhinitis, Perennial Allergic Rhinitis, Chronic idiopathic urticaria, Allergic asthma conditions, Nasal allergy with congestion.
Description:
This triple-action respiratory tablet combines Doxofylline (a bronchodilator), Levocetirizine (a modern antihistamine), and Montelukast (a leukotriene receptor antagonist). It provides comprehensive management of allergic respiratory disorders, including asthma, allergic rhinitis, chronic bronchitis, and COPD with allergy-related symptoms.
Doxofylline relaxes bronchial muscles and enhances airway airflow. Levocetirizine blocks histamine to relieve allergy symptoms like sneezing and runny nose. Montelukast reduces inflammation and prevents bronchoconstriction.
Tags:
- Relieves airway obstruction in asthma and bronchitis
- Controls runny nose, sneezing, watery eyes
- Reduces inflammation and allergic swelling in lungs
- Improves lung function and breathing comfort
- Convenient once-daily dosing
Usage Information
Dosage
Adults: One tablet once daily in the evening or as directed by physician Swallow whole with water; do not chew or crush
Side Effects
Headache, dizziness Dry mouth, nausea Mild drowsiness or fatigue Gastrointestinal discomfort Rare: Rash or allergic reaction
Contraindications
Hypersensitivity to any component of the formulation Caution in hepatic or renal impairment Not recommended in children below 12 years unless prescribed Use under medical advice during pregnancy or lactation Avoid alcohol and sedatives
Availability
Doxofylline Montelukast Levocetirizine • Asthma and allergy tablet • Anti-asthmatic antihistamine combo • COPD with allergic rhinitis medicine • Triple action respiratory tablet